ACTI — Active Biotech AB publ Balance Sheet
0.000.00%
- SEK95.65m
- SEK71.44m
Annual balance sheet for Active Biotech AB publ, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 26.2 | 53.1 | 41.8 | 36.2 | 27.4 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.51 | 1.19 | 0.947 | 1.25 | 9.5 |
Prepaid Expenses | |||||
Total Current Assets | 30.3 | 55.9 | 44.1 | 38.7 | 39.2 |
Net Property, Plant And Equipment | 1.87 | 0.945 | 6.26 | 4.72 | 3.35 |
Net Intangible Assets | |||||
Long Term Notes Receivable | |||||
Total Assets | 32.2 | 56.8 | 51 | 44 | 43.2 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 9.35 | 9.9 | 12.1 | 10.4 | 8.91 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 10 | 10.1 | 16.5 | 13.4 | 10.4 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 22.1 | 46.7 | 34.5 | 30.7 | 32.7 |
Total Liabilities & Shareholders' Equity | 32.2 | 56.8 | 51 | 44 | 43.2 |
Total Common Shares Outstanding |